Skip to main content

Werewolf Therapeutics, Inc.

corporate_fare Company Profile

Werewolf Therapeutics, Inc.

HOWL·NASDAQ·Life Sciences·CIK 0001785530

We are an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. We leverage our proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity. Our molecules, referred to as INDUKINE and INDUCER molecules, are intended to activate selectively in the tumor microenvironment, or TME. Our most advanced product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2) and Interleukin-12 (IL-12), respectively, INDUKINE molecules for the treatment of multiple tumor types. We also utilize the PREDATOR platform know-how and expertise to develop conditionally activated immune cell engagers. Immune cell engagers, such as T cell engagers, are typically bispecific antibodies that redirect immune cells to cancer cells via engagement with tumor associated cell surface antigens, leading to immune cell mediated killing of the cancer cells. We have provided initial preclinical data for our proprietary INDUCER™ T cell engager molecules demonstrating that our PREDATOR masking technology silenced peripheral activity and prevented cytokine release. In February 2026, we adopted a restructuring plan and our board of directors approved a reduction in force, representing 64% of our workforce. We have engaged Piper Sandler & Co, or Piper Sandler, as exclusive financial advisor to assist in the strategic review process.

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 39 items for HOWL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for HOWL spans 10-Q, S-4/A, 8-K, S-4.

Recent high-impact activity:

  • Werewolf Q3: $41.9M Cash, Going Concern, Dec 17 Merger Vote
  • Werewolf Sets Dec 17 Vote on Ambros Reverse Merger, 12:1-20:1 Reverse Split
  • Werewolf Reports WTX-124 Response Rates Up to 37.5% and FDA-Aligned Phase 2 Dose
  • Werewolf S-4 Amendment Sets Proxy Vote on $500M Ambros Reverse Merger and $150M PIPE
  • Werewolf Files S-4 for Reverse Merger with Ambros: $150M PIPE, 72% Ambros Ownership, CVR for Legacy Assets

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$60.82M
Diluted EPS
-$1.33
Op. Cash Flow
-$60.29M
Free Cash Flow
-$60.29M
Operating Income
-$60.68M
Cash & Equivalents
$57.05M
Total Debt
$32.09M
Debt / Equity
1.29×
Shares Outstanding
48.6M sh
Source: 10-K · filed 2026-03-27 · accession 0001785530-26-000006

Short Interest & Short Volume

6.39 days to cover

FINRA reported short interest of 2,128,661 shares in HOWL as of the October 30, 2026 settlement, a 9.7% decrease from the prior period — about 6.4 days to cover at its recent average daily volume. On November 20, 2026, 49.5% of HOWL volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,128,661 shares as of October 30, 2026
Change vs prior period▼ 9.7%
Days to cover6.39 at avg daily volume of 333,048
Daily short volume (FINRA facilities)49.5% of 125,953 shares on November 20, 2026
5-day average short volume37.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with H →
$0.95 +0.36% today
52-week range · as of 2026-11-13 $0.27 – $1.2
Market cap
$46M
Volume
374K (0.9× avg)
3-mo avg 436.4K
Live data · 2026-11-22 04:04 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed HOWL - Latest Insights

HOWL
Nov 13, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.9836
Real-time Price: $0.950 info
Change: -$0.0336 (-3%) info
Market Cap: $46.004M info
HOWL
Nov 10, 2026, 4:37 PM EST
Filing Type: S-4/A
Importance Score:
8
Price at Filing: $0.970
Real-time Price: $0.950 info
Change: -$0.020 (-2%) info
Market Cap: $46.004M info
HOWL
Nov 09, 2026, 9:22 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.00
Real-time Price: $0.950 info
Change: -$0.050 (-5%) info
Market Cap: $46.004M info
HOWL
Oct 26, 2026, 5:23 PM EDT
Filing Type: S-4/A
Importance Score:
8
Price at Filing: $0.9806
Real-time Price: $0.950 info
Change: -$0.0306 (-3%) info
Market Cap: $46.004M info
HOWL
Sep 22, 2026, 5:04 PM EDT
Filing Type: S-4
Importance Score:
9
Price at Filing: $0.9707
Real-time Price: $0.950 info
Change: -$0.0207 (-2%) info
Market Cap: $46.004M info
HOWL
Aug 21, 2026, 9:12 AM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $1.04
Real-time Price: $0.950 info
Change: -$0.0915 (-9%) info
Market Cap: $46.004M info
HOWL
Aug 21, 2026, 9:10 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.04
Real-time Price: $0.950 info
Change: -$0.0915 (-9%) info
Market Cap: $46.004M info
HOWL
Aug 21, 2026, 8:51 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.994096
Real-time Price: $0.950 info
Change: -$0.044096 (-4%) info
Market Cap: $46.004M info
HOWL
Aug 21, 2026, 8:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $0.7528
Real-time Price: $0.950 info
Change: +$0.1972 (+26%) info
Market Cap: $46.004M info
HOWL
Aug 20, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7418
Real-time Price: $0.950 info
Change: +$0.2082 (+28%) info
Market Cap: $46.004M info
HOWL
Jul 31, 2026, 7:10 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.490
Real-time Price: $0.950 info
Change: +$0.460 (+94%) info
Market Cap: $46.004M info
HOWL
Jul 31, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.490
Real-time Price: $0.950 info
Change: +$0.460 (+94%) info
Market Cap: $46.004M info
HOWL
Jul 06, 2026, 5:18 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $0.315
Real-time Price: $0.950 info
Change: +$0.635 (+202%) info
Market Cap: $46.004M info
HOWL
Jul 02, 2026, 8:26 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.330
Real-time Price: $0.950 info
Change: +$0.620 (+188%) info
Market Cap: $46.004M info
HOWL
Jun 26, 2026, 5:39 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.323
Real-time Price: $0.950 info
Change: +$0.627 (+194%) info
Market Cap: $46.004M info
HOWL
Jun 22, 2026, 7:02 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.3541
Real-time Price: $0.950 info
Change: +$0.5959 (+168%) info
Market Cap: $46.004M info
HOWL
Jun 16, 2026, 6:01 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.3672
Real-time Price: $0.950 info
Change: +$0.5828 (+159%) info
Market Cap: $46.004M info
HOWL
Jun 15, 2026, 8:16 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.396
Real-time Price: $0.950 info
Change: +$0.554 (+140%) info
Market Cap: $46.004M info
HOWL
Jun 11, 2026, 8:13 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.3867
Real-time Price: $0.950 info
Change: +$0.5633 (+146%) info
Market Cap: $46.004M info
HOWL
May 28, 2026, 5:02 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $0.4729
Real-time Price: $0.950 info
Change: +$0.4771 (+101%) info
Market Cap: $46.004M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets